News & Events

Antitrust Associate Lindsey Bohl was featured in a Q&A article in the ABA Antitrust Health Care Chronicle surrounding her former experience as a staff attorney in the FTC’s Mergers IV Division, where she led significant healthcare and retail transaction investigations, including her role as team lead on the 2020 Hackensack Meridian Health, Inc./Englewood Healthcare Foundation hospital merger investigation and core role on the FTC v. Hackensack litigation team. Lindsey noted that the case has informed her analysis and advice at Simpson Thacher, adding that her takeaways include that “the FTC does not necessarily apply one specific formula to defining a relevant geographic market and demonstrating that the market passes the hypothetical monopolist test,” internal documents generated by parties and consultants are critical evidence for the FTC and merging parties’ track record may be important.

To read the full article, please click here.